Magellan Health Stock Price, News & Analysis (NASDAQ:MGLN)

$96.45 +1.80 (+1.90 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$96.45
Today's Range$94.50 - $97.50
52-Week Range$64.05 - $102.70
Volume87,450 shs
Average Volume131,722 shs
Market Capitalization$2.36 billion
P/E Ratio25.52
Dividend YieldN/A
Beta0.52

About Magellan Health (NASDAQ:MGLN)

Magellan Health logoMagellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryManaged Health Care
SectorHealthcare
SymbolNASDAQ:MGLN
CUSIP55907920
Phone+1-602-5726050

Debt

Debt-to-Equity Ratio0.62%
Current Ratio2.28%
Quick Ratio2.21%

Price-To-Earnings

Trailing P/E Ratio25.515873015873
Forward P/E Ratio18.58
P/E Growth1.11

Sales & Book Value

Annual Sales$4.84 billion
Price / Sales0.48
Cash Flow$9.38 per share
Price / Cash10.28
Book Value$47.32 per share
Price / Book2.04

Profitability

Trailing EPS$3.78
Net Income$77.87 million
Net Margins1.68%
Return on Equity9.20%
Return on Assets4.21%

Miscellaneous

Employees9,700
Outstanding Shares24,040,000

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.24. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.49 billion. Magellan Health had a return on equity of 9.20% and a net margin of 1.68%. Magellan Health's revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.39 EPS. View Magellan Health's Earnings History.

When will Magellan Health make its next earnings announcement?

Magellan Health is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY18 earnings guidance on Friday, December, 1st. The company provided EPS guidance of $5.68-6.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.79. The company issued revenue guidance of $7.5-7.8 billion or $7.0-7.3 billion ex acquisition, compared to the consensus revenue estimate of $7.13 billion.

Where is Magellan Health's stock going? Where will Magellan Health's stock price be in 2018?

4 brokerages have issued 1-year price targets for Magellan Health's shares. Their predictions range from $73.00 to $105.00. On average, they anticipate Magellan Health's stock price to reach $90.67 in the next twelve months. View Analyst Ratings for Magellan Health.

What are Wall Street analysts saying about Magellan Health stock?

Here are some recent quotes from research analysts about Magellan Health stock:

  • 1. According to Zacks Investment Research, "Magellan Health Inc. is an American for-profit managed health care company, focused on behavioral healthcare. As a specialty health care manager, they focus on some of today's most complex and costly health care services. The depth and breadth of experience in managing behavioral health care, diagnostic imaging, specialty pharmaceutical services and providing pharmacy benefits administration enables us to deliver invaluable insights and innovative solutions that positively impact both the quality and the cost of some of the nation's fastest growing areas of health care. Maintaining the highest level of integrity and clinical and quality excellence have long been Magellan hallmarks. By working together with health plans, employers, government agencies, consumers, service providers, fellow employees and many other stakeholders, they get a full perspective of the situation and are able to leverage these partnerships to deliver effective and innovative solutions. " (2/7/2018)
  • 2. Jefferies Group LLC analysts commented, "We believe mixed 4Q results and a small EPS guidance reduction (share count related) on the heels of MGLN's 50%+ surge (vs S&P's +10%) since early November are causing shares to pull back today (down 7-8% vs S&P's -0.2%). 4Q16 revenue was soft, but that's largely due to a short delay in starting new work. We think fundamentals remain broadly strong and remain Buy rated, but we modestly reduce our earnings projections and PT for higher Pharmacy uncertainty." (2/24/2017)

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:

  • Barry Michael Smith, Executive Chairman of the Board, Chief Executive Officer (Age 64)
  • Mostafa Kamal, Chief Executive Officer of Magellan Rx Management (Age 36)
  • Sanjeev K. Srivastava, Chief Executive Officer - Magellan Healthcare (Age 49)
  • Caskie R. Lewis-Clapper, Chief Human Resource Officer (Age 52)
  • Daniel N. Gregoire, General Counsel, Secretary (Age 61)
  • William J. McBride, Lead Independent Director (Age 72)
  • John O. Agwunobi M.D., Independent Director (Age 52)
  • Eran Broshy, Independent Director (Age 58)
  • Michael S. Diament, Independent Director (Age 48)
  • Perry G. Fine M.D., Independent Director (Age 64)

Who owns Magellan Health stock?

Magellan Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.34%), Renaissance Technologies LLC (4.34%), LSV Asset Management (3.38%), Fisher Asset Management LLC (2.96%), Millennium Management LLC (2.45%) and Hood River Capital Management LLC (2.29%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Who sold Magellan Health stock? Who is selling Magellan Health stock?

Magellan Health's stock was sold by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., Renaissance Technologies LLC, Bank of Montreal Can, Peregrine Capital Management LLC, TIAA CREF Investment Management LLC, Citadel Advisors LLC, Goldman Sachs Group Inc. and Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health.

Who bought Magellan Health stock? Who is buying Magellan Health stock?

Magellan Health's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Assenagon Asset Management S.A., AXA, Mackenzie Financial Corp, Hood River Capital Management LLC, Millennium Management LLC, James Investment Research Inc. and Deutsche Bank AG. View Insider Buying and Selling for Magellan Health.

How do I buy Magellan Health stock?

Shares of Magellan Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of Magellan Health stock can currently be purchased for approximately $96.45.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $2.36 billion and generates $4.84 billion in revenue each year. The company earns $77.87 million in net income (profit) each year or $3.78 on an earnings per share basis. Magellan Health employs 9,700 workers across the globe.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 N Scottsdale Rd Ste 4400, SCOTTSDALE, AZ 85251-7680, United States. The company can be reached via phone at +1-602-5726050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  213 (Vote Outperform)
Underperform Votes:  207 (Vote Underperform)
Total Votes:  420
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Magellan Health (NASDAQ:MGLN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.753.002.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $90.67$90.67$85.33$80.25
Price Target Upside: 1.53% upside1.53% upside1.71% upside3.35% upside

Magellan Health (NASDAQ:MGLN) Consensus Price Target History

Price Target History for Magellan Health (NASDAQ:MGLN)

Magellan Health (NASDAQ:MGLN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/2/2017Raymond James FinancialReiterated RatingHoldHighView Rating Details
12/1/2017KeyCorpSet Price TargetBuy$105.00HighView Rating Details
10/13/2017Jefferies GroupReiterated RatingBuy$94.00N/AView Rating Details
6/25/2017Leerink SwannReiterated RatingOutperform$68.00 -> $73.00LowView Rating Details
11/23/2016BarclaysBoost Price TargetUnderweight$61.00 -> $69.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Magellan Health (NASDAQ:MGLN) Earnings History and Estimates Chart

Earnings by Quarter for Magellan Health (NASDAQ:MGLN)

Magellan Health (NASDAQ MGLN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018        
11/1/2017Q3 2017$1.40$1.64$1.49 billion$1.42 billionViewN/AView Earnings Details
7/28/2017Q2 2017$0.94$0.46$1.40 billion$1.42 billionViewN/AView Earnings Details
4/26/2017Q1 2017$0.70$0.74$1.33 billion$1.31 billionViewN/AView Earnings Details
2/24/2017Q416$1.68$1.80$1.33 billion$1.26 billionViewN/AView Earnings Details
11/9/2016Q316$0.67$1.39$1.22 billion$1.29 billionViewListenView Earnings Details
7/29/2016Q216$0.62$0.58$1.15 billion$1.16 billionViewListenView Earnings Details
5/5/2016Q116$0.55$0.54$1.04 billion$1.12 billionViewN/AView Earnings Details
2/29/2016Q415$0.83$1.39$1.23 billion$1.27 billionViewListenView Earnings Details
10/27/2015Q315$0.49$0.53$1.19 billion$1.19 billionViewListenView Earnings Details
7/27/2015Q215$0.38$0.17$1.09 billion$1.16 billionViewListenView Earnings Details
4/30/2015Q115$0.38$0.73$1.02 billion$981.00 millionViewN/AView Earnings Details
2/26/2015Q414$0.49$1.04$980.37 million$982.50 millionViewListenView Earnings Details
10/24/2014Q314$0.44$1.09$930.10 million$823.20 millionViewListenView Earnings Details
7/25/2014Q214$0.56$0.25$863.10 million$888.00 millionViewListenView Earnings Details
4/29/2014Q114$0.75$0.92$1,000.00 million$966.50 millionViewListenView Earnings Details
3/3/2014Q413$0.83$0.67$990.55 million$1.01 millionViewN/AView Earnings Details
10/24/2013Q313$1.01$1.70$875.26 million$873.60 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.01$1.15$852.42 million$842.70 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.88$1.01$864.04 million$821.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$1.05$1.32$835.55 million$830.30 millionViewN/AView Earnings Details
10/26/2012Q312$0.96$1.12$845.16 million$798.40 millionViewN/AView Earnings Details
7/27/2012$0.91$0.97ViewN/AView Earnings Details
4/27/2012$0.90$0.75ViewN/AView Earnings Details
2/28/2012$0.77$1.05ViewN/AView Earnings Details
10/27/2011$0.84$1.03ViewN/AView Earnings Details
7/29/2011$0.86$1.07ViewN/AView Earnings Details
4/29/2011$0.79$1.02ViewN/AView Earnings Details
2/24/2011$0.91$0.95ViewN/AView Earnings Details
10/29/2010Q3 2010$0.92$1.31ViewN/AView Earnings Details
7/29/2010Q2 2010$0.73$1.05ViewN/AView Earnings Details
4/30/2010Q1 2010$0.65$0.73ViewN/AView Earnings Details
2/26/2010Q4 2009$1.04$1.25ViewN/AView Earnings Details
10/30/2009Q3 2009$0.66$0.88ViewN/AView Earnings Details
7/31/2009Q2 2009$0.53$0.53ViewN/AView Earnings Details
4/30/2009Q1 2009$0.51$0.37ViewN/AView Earnings Details
2/27/2009Q4 2008$0.55$0.61ViewN/AView Earnings Details
10/31/2008Q3 2008$0.53$0.58ViewN/AView Earnings Details
7/31/2008Q2 2008$0.47$0.54ViewN/AView Earnings Details
5/2/2008Q1 2008$0.45$0.43ViewN/AView Earnings Details
2/29/2008Q4 2007$0.65$0.78ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Magellan Health (NASDAQ:MGLN) Earnings Estimates

Current Year EPS Consensus Estimate: $5.19 EPS
Next Year EPS Consensus Estimate: $5.89 EPS

Dividends

Dividend History for Magellan Health (NASDAQ:MGLN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Magellan Health (NASDAQ MGLN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 96.38%
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)

Magellan Health (NASDAQ MGLN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/1/2018Barry M SmithCEOSell13,375$99.20$1,326,800.0042,807View SEC Filing  
1/2/2018Barry M SmithCEOSell13,367$95.94$1,282,429.9842,799View SEC Filing  
1/2/2018Jonathan N RubinCFOSell17,443$96.07$1,675,749.0143,890View SEC Filing  
12/4/2017Clapper Caskie LewisInsiderSell59,313$93.99$5,574,828.8748,474View SEC Filing  
12/4/2017Mostafa KamalCEOSell2,180$92.00$200,560.002,180View SEC Filing  
12/1/2017Daniel N GregoireGeneral CounselSell8,275$89.08$737,137.0016,690View SEC Filing  
11/1/2017Daniel N GregoireGeneral CounselSell9,369$89.20$835,714.8022,826View SEC Filing  
11/1/2017Mostafa KamalCEOSell1,154$92.00$106,168.001,154View SEC Filing  
10/4/2017Daniel N GregoireGeneral CounselSell12,475$88.02$1,098,049.50View SEC Filing  
10/3/2017Jeffrey N WestSVPSell30,021$87.31$2,621,133.51View SEC Filing  
10/2/2017Jeffrey N WestSVPSell19,007$86.22$1,638,783.5426,962View SEC Filing  
9/29/2017Jeffrey N WestSVPSell18,511$86.18$1,595,277.9829,395View SEC Filing  
9/28/2017Jeffrey N WestSVPSell25,316$85.85$2,173,378.6029,243View SEC Filing  
9/28/2017Mostafa KamalCEOSell4,848$85.76$415,764.484,848View SEC Filing  
9/27/2017Daniel N GregoireGeneral CounselSell35,658$85.17$3,036,991.8649,115View SEC Filing  
9/27/2017Jeffrey N WestSVPSell19,921$85.30$1,699,261.3019,511View SEC Filing  
9/27/2017Mostafa KamalCEOSell19,126$85.33$1,632,021.5811,819View SEC Filing  
9/15/2017Daniel N GregoireGeneral CounselSell20,465$83.05$1,699,618.2531,520View SEC Filing  
9/15/2017Mostafa KamalCEOSell2,961$84.00$248,724.002,961View SEC Filing  
9/13/2017Daniel N GregoireGeneral CounselSell14,096$83.06$1,170,813.7627,553View SEC Filing  
9/13/2017Mostafa KamalCEOSell604$83.00$50,132.0019View SEC Filing  
9/11/2017Daniel N GregoireGeneral CounselSell2,400$83.00$199,200.0015,857View SEC Filing  
9/11/2017Mostafa KamalCEOSell670$83.00$55,610.00670View SEC Filing  
9/8/2017Mostafa KamalCEOSell6,267$81.53$510,948.516,267View SEC Filing  
9/7/2017Mostafa KamalCEOSell2,190$81.07$177,543.30157View SEC Filing  
7/25/2017Daniel N GregoireGeneral CounselSell4,559$80.68$367,820.1218,016View SEC Filing  
7/24/2017Daniel N GregoireGeneral CounselSell33,574$80.11$2,689,613.1414,633View SEC Filing  
7/20/2017Daniel N GregoireGeneral CounselSell16,073$80.06$1,286,804.3829,530View SEC Filing  
7/20/2017Jeffrey N WestSVPSell1,109$80.01$88,731.0915,040View SEC Filing  
7/17/2017Jeffrey N WestSVPSell28,514$80.07$2,283,115.9817,085View SEC Filing  
7/14/2017Daniel N GregoireGeneral CounselSell14,114$80.11$1,130,672.5427,573View SEC Filing  
2/24/2017Jeffrey N WestSVPSell13,512$80.31$1,085,148.7224,587View SEC Filing  
2/23/2017Eran BroshyDirectorSell4,867$80.00$389,360.007,960View SEC Filing  
2/3/2017Jeffrey N WestSVPSell15,055$76.46$1,151,105.3018,248View SEC Filing  
2/1/2017Jeffrey N WestSVPSell3,346$76.05$254,463.3012,903View SEC Filing  
12/8/2016Clapper Caskie LewisInsiderSell55,590$74.43$4,137,563.7033,029View SEC Filing  
12/7/2016Jonathan N RubinCFOSell42,966$73.27$3,148,118.8233,134View SEC Filing  
12/5/2016Jonathan N RubinCFOSell1,600$73.05$116,880.0021,721View SEC Filing  
12/1/2016Jonathan N RubinCFOSell1,150$73.23$84,214.5021,271View SEC Filing  
11/30/2016Jonathan N RubinCFOSell7,620$73.01$556,336.2027,741View SEC Filing  
11/29/2016Jonathan N RubinCFOSell7,177$73.01$523,992.7727,298View SEC Filing  
7/12/2016Jeffrey N WestSVPBuy267$51.99$13,881.3311,375View SEC Filing  
1/15/2016Jeffrey N WestSVPBuy105$52.41$5,503.0510,730View SEC Filing  
7/15/2015Jeffrey N WestSVPBuy298$50.22$14,965.56View SEC Filing  
3/19/2015Daniel N GregoireGeneral CounselSell26,232$68.47$1,796,105.04View SEC Filing  
3/16/2015Daniel N GregoireGeneral CounselSell15,528$66.80$1,037,270.40View SEC Filing  
3/16/2015Jonathan N RubinCFOSell21,270$66.59$1,416,369.30View SEC Filing  
3/13/2015Daniel N GregoireGeneral CounselSell9,765$66.21$646,540.65View SEC Filing  
3/2/2015Daniel N GregoireGeneral CounselSell20,365$64.48$1,313,135.20View SEC Filing  
6/30/2014Daniel N GregoireGeneral CounselSell21,675$62.25$1,349,268.75View SEC Filing  
6/26/2014Jonathan N RubinCFOSell29,700$61.92$1,839,024.00View SEC Filing  
6/25/2014Jonathan N RubinCFOSell18,400$62.40$1,148,160.00View SEC Filing  
6/24/2014Jonathan N RubinCFOSell19,200$62.46$1,199,232.00View SEC Filing  
6/23/2014Jonathan N RubinCFOSell21,700$62.73$1,361,241.00View SEC Filing  
6/20/2014Jonathan N RubinCFOSell31,200$62.99$1,965,288.00View SEC Filing  
6/19/2014Jonathan N RubinCFOSell18,600$62.73$1,166,778.00View SEC Filing  
6/18/2014Jonathan N RubinCFOSell35,896$62.79$2,253,909.84View SEC Filing  
6/17/2014Jonathan N RubinCFOSell23,996$62.22$1,493,031.12View SEC Filing  
6/16/2014Jonathan N RubinCFOSell13,041$62.18$810,889.38View SEC Filing  
6/16/2014Tina BlasiCEOSell10,775$62.07$668,804.25View SEC Filing  
6/13/2014Tina BlasiCEOSell10,247$62.03$635,621.41View SEC Filing  
5/19/2014Barry SmithCEOBuy10,000$58.56$585,600.0013,427View SEC Filing  
5/14/2014Robert LeblancDirectorBuy10,000$55.60$556,000.0029,939View SEC Filing  
3/6/2014Tina BlasiCEOSell10,527$60.42$636,041.348,353View SEC Filing  
12/20/2013Daniel GregoireGeneral CounselSell10,631$58.00$616,598.006,877View SEC Filing  
12/3/2013Rene LererChairmanSell28,321$61.01$1,727,864.2184,089View SEC Filing  
12/2/2013Rene LererChairmanSell36,000$61.30$2,206,800.0084,089View SEC Filing  
11/26/2013Rene LererChairmanSell5,055$60.75$307,091.2584,089View SEC Filing  
11/22/2013Rene LererChairmanSell14,700$60.67$891,849.0084,089View SEC Filing  
11/18/2013Rene LererChairmanSell33,215$61.34$2,037,408.1084,089View SEC Filing  
11/14/2013Rene LererDirectorSell52,541$59.99$3,151,934.5984,089View SEC Filing  
11/12/2013Rene LererChairmanSell36,500$59.34$2,165,910.0084,089View SEC Filing  
11/8/2013Rene LererChairmanSell15,200$59.62$906,224.0084,089View SEC Filing  
11/6/2013Rene LererChairmanSell96,773$59.27$5,735,735.7184,089View SEC Filing  
11/4/2013Rene LererChairmanSell62,900$59.01$3,711,729.00View SEC Filing  
10/24/2013Tina BlasiCEOSell12,331$62.00$764,522.00View SEC Filing  
7/11/2013Jonathan N RubinCFOSell24,500$57.53$1,409,485.00View SEC Filing  
7/9/2013Jonathan N RubinCFOSell27,950$57.92$1,618,864.00View SEC Filing  
7/8/2013Jonathan N RubinCFOSell6,150$57.05$350,857.50View SEC Filing  
6/19/2013Jonathan N RubinCFOSell1,600$57.06$91,296.00View SEC Filing  
6/3/2013Clapper Caskie LewisInsiderSell43,399$55.00$2,386,945.00View SEC Filing  
5/31/2013Clapper Caskie LewisInsiderSell14,002$55.00$770,110.00View SEC Filing  
10/5/2012Tina BlasiCEOSell3,000$52.06$156,180.00View SEC Filing  
10/3/2012Tina BlasiCEOSell1,955$52.03$101,718.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Magellan Health (NASDAQ MGLN) News Headlines

Source:
DateHeadline
Magellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Floridians Impacted by the High School Shooting in Parkland, FloridaMagellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Floridians Impacted by the High School Shooting in Parkland, Florida
finance.yahoo.com - February 15 at 8:57 AM
Magellan Health (MGLN) to Release Earnings on ThursdayMagellan Health (MGLN) to Release Earnings on Thursday
www.americanbankingnews.com - February 15 at 2:02 AM
Magellan Health Inc (MGLN) Receives Average Recommendation of "Buy" from BrokeragesMagellan Health Inc (MGLN) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - February 14 at 1:38 PM
 Brokerages Anticipate Magellan Health Inc (MGLN) Will Announce Quarterly Sales of $1.62 Billion Brokerages Anticipate Magellan Health Inc (MGLN) Will Announce Quarterly Sales of $1.62 Billion
www.americanbankingnews.com - February 8 at 5:26 AM
Magellan Health (MGLN) Stock Rating Upgraded by ValuEngineMagellan Health (MGLN) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - February 4 at 10:18 PM
Magellan Health Inc (MGLN) CEO Sells $1,326,800.00 in StockMagellan Health Inc (MGLN) CEO Sells $1,326,800.00 in Stock
www.americanbankingnews.com - February 2 at 3:14 PM
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Affected by Hawaii False Emergency AlertMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Affected by Hawaii False Emergency Alert
finance.yahoo.com - January 22 at 5:36 PM
$1.62 Billion in Sales Expected for Magellan Health Inc (MGLN) This Quarter$1.62 Billion in Sales Expected for Magellan Health Inc (MGLN) This Quarter
www.americanbankingnews.com - January 22 at 6:56 AM
Magellan Health Inc (MGLN) Receives Consensus Rating of "Buy" from AnalystsMagellan Health Inc (MGLN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - January 20 at 1:40 PM
Magellan Health Inc (MGLN) Expected to Post Earnings of $2.30 Per ShareMagellan Health Inc (MGLN) Expected to Post Earnings of $2.30 Per Share
www.americanbankingnews.com - January 20 at 1:14 PM
Magellan Health, Inc. -- Moodys assigns Ba1 rating to Magellan Health, stable outlookMagellan Health, Inc. -- Moody's assigns Ba1 rating to Magellan Health, stable outlook
finance.yahoo.com - January 18 at 4:47 PM
Magellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use DisorderMagellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use Disorder
finance.yahoo.com - January 16 at 5:11 PM
Coventry Health Care (CVH) vs. Magellan Health (MGLN) Head-To-Head ContrastCoventry Health Care (CVH) vs. Magellan Health (MGLN) Head-To-Head Contrast
www.americanbankingnews.com - January 5 at 9:32 AM
Magellan Health Inc (MGLN) Expected to Announce Quarterly Sales of $1.62 BillionMagellan Health Inc (MGLN) Expected to Announce Quarterly Sales of $1.62 Billion
www.americanbankingnews.com - January 5 at 9:02 AM
Jonathan N. Rubin Sells 17,443 Shares of Magellan Health Inc (MGLN) StockJonathan N. Rubin Sells 17,443 Shares of Magellan Health Inc (MGLN) Stock
www.americanbankingnews.com - January 3 at 9:26 PM
Magellan Health Inc (MGLN) CEO Barry M. Smith Sells 13,367 SharesMagellan Health Inc (MGLN) CEO Barry M. Smith Sells 13,367 Shares
www.americanbankingnews.com - January 3 at 9:26 PM
Magellan Health Inc (MGLN) Given Average Rating of "Buy" by AnalystsMagellan Health Inc (MGLN) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 26 at 2:10 PM
Tenet Plans to Sell Conifer And Reduce Costs, Issues 2018 ViewTenet Plans to Sell Conifer And Reduce Costs, Issues 2018 View
www.benzinga.com - December 21 at 9:39 AM
Tenet Plans to Sell Conifer & Reduce Costs, Issues '18 ViewTenet Plans to Sell Conifer & Reduce Costs, Issues '18 View
finance.yahoo.com - December 20 at 9:40 AM
WellCare Health (WCG) 2018 Guidance: Whats in the Cards?WellCare Health (WCG) 2018 Guidance: What's in the Cards?
finance.yahoo.com - December 19 at 5:13 PM
WellCare Health (WCG) 2018 Guidance: What's in the Cards?WellCare Health (WCG) 2018 Guidance: What's in the Cards?
finance.yahoo.com - December 19 at 5:13 PM
BidaskClub Downgrades Magellan Health (MGLN) to BuyBidaskClub Downgrades Magellan Health (MGLN) to Buy
www.americanbankingnews.com - December 19 at 6:46 AM
Innovative Collaboration Takes on Cardiovascular HealthInnovative Collaboration Takes on Cardiovascular Health
finance.yahoo.com - December 18 at 5:12 PM
$2.30 EPS Expected for Magellan Health Inc (MGLN) This Quarter$2.30 EPS Expected for Magellan Health Inc (MGLN) This Quarter
www.americanbankingnews.com - December 18 at 1:32 AM
Magellan Health (MGLN) Raised to "Strong-Buy" at Zacks Investment ResearchMagellan Health (MGLN) Raised to "Strong-Buy" at Zacks Investment Research
www.americanbankingnews.com - December 17 at 1:38 PM
Magellan Health (MGLN) Upgraded at BidaskClubMagellan Health (MGLN) Upgraded at BidaskClub
www.americanbankingnews.com - December 9 at 1:38 PM
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by the High School Shooting in Aztec, New MexicoMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by the High School Shooting in Aztec, New Mexico
finance.yahoo.com - December 9 at 9:39 AM
Mostafa Kamal Sells 2,180 Shares of Magellan Health Inc (MGLN) StockMostafa Kamal Sells 2,180 Shares of Magellan Health Inc (MGLN) Stock
www.americanbankingnews.com - December 6 at 2:34 PM
Insider Selling: Magellan Health Inc (MGLN) Insider Sells 59,313 Shares of StockInsider Selling: Magellan Health Inc (MGLN) Insider Sells 59,313 Shares of Stock
www.americanbankingnews.com - December 5 at 11:22 PM
Magellan Health, Inc. – Value Analysis (NASDAQ:MGLN) : December 5, 2017Magellan Health, Inc. – Value Analysis (NASDAQ:MGLN) : December 5, 2017
finance.yahoo.com - December 5 at 5:10 PM
Magellan Health Inc (MGLN) General Counsel Daniel N. Gregoire Sells 8,275 SharesMagellan Health Inc (MGLN) General Counsel Daniel N. Gregoire Sells 8,275 Shares
www.americanbankingnews.com - December 4 at 2:34 PM
Magellan Health, Inc. breached its 50 day moving average in a Bullish Manner : MGLN-US : December 4, 2017Magellan Health, Inc. breached its 50 day moving average in a Bullish Manner : MGLN-US : December 4, 2017
finance.yahoo.com - December 4 at 9:35 AM
Magellan Health (MGLN) in Focus: Stock Moves 5.7% HigherMagellan Health (MGLN) in Focus: Stock Moves 5.7% Higher
finance.yahoo.com - December 4 at 9:35 AM
Magellan Health (MGLN) Stock Rating Reaffirmed by Raymond James FinancialMagellan Health (MGLN) Stock Rating Reaffirmed by Raymond James Financial
www.americanbankingnews.com - December 3 at 7:30 AM
KeyCorp Reiterates "$105.00" Price Target for Magellan Health (MGLN)KeyCorp Reiterates "$105.00" Price Target for Magellan Health (MGLN)
www.americanbankingnews.com - December 2 at 10:12 AM
Magellan Health Inc (MGLN) Given Consensus Rating of "Buy" by BrokeragesMagellan Health Inc (MGLN) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 1 at 10:04 PM
Magellan Health (MGLN) Releases FY18 Earnings GuidanceMagellan Health (MGLN) Releases FY18 Earnings Guidance
www.americanbankingnews.com - December 1 at 5:28 PM
Magellan Health (MGLN) FY18 EPS Tops Views at Mid-PointMagellan Health (MGLN) FY18 EPS Tops Views at Mid-Point
www.streetinsider.com - December 1 at 4:57 PM
Magellan Health Announces Full Year 2018 GuidanceMagellan Health Announces Full Year 2018 Guidance
finance.yahoo.com - December 1 at 4:57 PM
ETFs with exposure to Magellan Health, Inc. : December 1, 2017ETFs with exposure to Magellan Health, Inc. : December 1, 2017
finance.yahoo.com - December 1 at 4:57 PM
A Magellan Collaboration With Talkspace Confuses Patients And Increases RiskA Magellan Collaboration With Talkspace Confuses Patients And Increases Risk
www.forbes.com - November 22 at 5:05 AM
Magellan Health Leverages Talkspaces Messaging Therapy For Magellans Employer ClientsMagellan Health Leverages Talkspace's Messaging Therapy For Magellan's Employer Clients
www.thestreet.com - November 15 at 6:22 AM
Magellan Health Announces 2018 Financial Guidance CallMagellan Health Announces 2018 Financial Guidance Call
finance.yahoo.com - November 15 at 6:22 AM
Magellan Health, Inc. (MGLN) Expected to Post Earnings of $2.30 Per ShareMagellan Health, Inc. (MGLN) Expected to Post Earnings of $2.30 Per Share
www.americanbankingnews.com - November 11 at 10:22 AM
ETFs with exposure to Magellan Health, Inc. : November 6, 2017ETFs with exposure to Magellan Health, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 6:51 AM
Magellan Health Leverages Talkspace’s Messaging Therapy for Magellan’s Employer ClientsMagellan Health Leverages Talkspace’s Messaging Therapy for Magellan’s Employer Clients
finance.yahoo.com - November 7 at 6:51 AM
Magellan Health, Inc. (MGLN) Receives Average Rating of "Buy" from BrokeragesMagellan Health, Inc. (MGLN) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 6 at 6:11 PM
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted in Texas Church ShootingMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted in Texas Church Shooting
finance.yahoo.com - November 6 at 2:11 AM
Magellan Health, Inc. :MGLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017Magellan Health, Inc. :MGLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
finance.yahoo.com - November 3 at 5:43 PM
Insider Selling: Magellan Health, Inc. (MGLN) CEO Sells 1,154 Shares of StockInsider Selling: Magellan Health, Inc. (MGLN) CEO Sells 1,154 Shares of Stock
www.americanbankingnews.com - November 3 at 4:06 AM

SEC Filings

Magellan Health (NASDAQ:MGLN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Magellan Health (NASDAQ:MGLN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Magellan Health (NASDAQ MGLN) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.